Manchester United Target PSG's Donnarumma As Potential Onana Replacement: Report
Manchester United are eyeing PSG's Gianluigi Donnarumma as a potential goalkeeper addition. Nick Pope is also on their shortlist as a short-term option.
Not a day goes by without Manchester United being linked to a high-profile name during the transfer window.
The latest to emerge is Gianluigi Donnarumma, Paris Saint-Germain's first-choice goalkeeper and a mainstay for the Italian national team.
So far this summer, the Red Devils have added Matheus Cunha, Bryan Mbeumo, and Diego Leon to their ranks. But with the transfer window still open, INEOS are reportedly pushing for three more additions: a striker, a defensive midfielder, and a goalkeeper.
Among the names under serious consideration for the goalkeeper role is Donnarumma, 26, who has established himself as one of the world's top shot-stoppers.
United are not only seeking competition for André Onana, but are also open to a possible long-term replacement.
According to The Sun, Donnarumma has emerged as a priority target, though the Italian's price tag could reach €60 million, even with his contract at PSG set to expire in 2026. Interest from several top European clubs could further complicate any potential move.
Transfer insider Fabrizio Romano has also weighed in, revealing that no formal contact has been made between United and Donnarumma's camp at this stage.
While the club remains in the market for a goalkeeper, Romano emphasized that United are unwilling to be drawn into a bidding war, and will only proceed if the deal is financially viable.
PSG Open to Selling?
With contract extension talks stalling in Paris, PSG are reportedly open to selling Donnarumma to avoid the risk of losing him on a free transfer in 2026.
As speculation builds, Manchester United appear to be monitoring the situation closely.
view comments
Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
India Today
10 minutes ago
- India Today
Nations criticising India indulging in trade with Russia: India's full statement
India has firmly defended its oil imports from Russia, calling out the 'unjustified and unreasonable' criticism by the United States and European Union, and highlighting what it sees as double standards in the West's own trade with a strong statement, the Ministry of External Affairs said that India's energy imports are a matter of economic necessity, driven by global market shifts following the outbreak of the Ukraine conflict. The ministry pointed out that the US had in fact 'actively encouraged such imports by India to strengthen global energy markets stability.'advertisementHERE IS THE FULL STATEMENT RELEASED BY INDIA: 1. India has been targeted by the United States and the European Union for importing oil from Russia after the commencement of the Ukraine conflict. In fact, India began importing from Russia because traditional supplies were diverted to Europe after the outbreak of the conflict. The United States at that time actively encouraged such imports by India for strengthening global energy markets stability.2. India's imports are meant to ensure predictable and affordable energy costs to the Indian consumer. They are a necessity compelled by the global market situation. However, it is revealing that the very nations criticizing India are themselves indulging in trade with Russia. Unlike our case, such trade is not even a vital national compulsion.3. The European Union in 2024 had a bilateral trade of Euro 67.5 billion in goods with Russia. In addition, it had trade in services estimated at Euro 17.2 billion in 2023. This is significantly more than India's total trade with Russia that year or subsequently. European imports of LNG in 2024, in fact, reached a record 16.5mn tonnes, surpassing the last record of 15.21mn tonnes in 2022.4. Europe-Russia trade includes not just energy, but also fertilisers, mining products, chemicals, iron and steel and machinery and transport equipment.5. Where the United States is concerned, it continues to import from Russia uranium hexafluoride for its nuclear industry, palladium for its EV industry, fertilisers as well as chemicals.6. In this background, the targeting of India is unjustified and unreasonable. Like any major economy, India will take all necessary measures to safeguard its national interests and economic security.- EndsTune InMust Watch
&w=3840&q=100)
Business Standard
10 minutes ago
- Business Standard
Aurobindo Pharma Q1 PAT falls 10% on drop in API sales, US market revenue
Aurobindo Pharma on Monday reported a 10.2% year-on-year (Y-o-Y) drop in consolidated profit after tax (PAT) for the June quarter (Q1 FY26), which stood at Rs 824 crore. The decline was attributed to a drop in sales in its active pharmaceutical ingredients (API) business and the United States (US) market. The Hyderabad-based drugmaker had recorded a net profit of Rs 918 crore in Q1 FY25. The company stated that its API business was affected by pricing pressures and geopolitical tensions, with revenues for the segment falling by 16% Y-o-Y to Rs 916 crore in Q1 FY26. However, the drugmaker recorded a 4% Y-o-Y rise in revenue from operations, reaching Rs 7,868 crore in the June quarter, up from Rs 7,567 crore in Q1 FY25. This increase was primarily driven by a 7.4% Y-o-Y rise in the drugmaker's formulations business revenue, which contributes around 85% of the company's overall revenue. Aurobindo Pharma saw an 18% Y-o-Y revenue growth in European markets, which stood at Rs 2,338 crore, driven by a strong performance across all key markets. Similarly, revenue from growth markets formulations increased by 8.8% Y-o-Y to Rs 772 crore in the June quarter, compared to Rs 709 crore in the same period last year. However, the company's US formulations business, which accounts for 44% of its revenue, saw a marginal 1.9% Y-o-Y dip in sales, from Rs 3,555 crore in Q1 FY25 to Rs 3,488 crore in Q1 FY26. According to the company's regulatory filing, the decline in US revenue was primarily due to a significant reduction in sales of the anti-cancer medication lenalidomide. Commenting on the company's performance, K. Nithyananda Reddy, Vice Chairman and Managing Director of Aurobindo Pharma, said that the company has started FY26 steadily, with its European business maintaining strong growth momentum and the core US business showing resilience despite temporary challenges from destocking and seasonal dynamics. The company announced its results after market hours. On Monday, Aurobindo Pharma's shares rose marginally by 1.04%, ending the day's trade at Rs 1,090.90 apiece on the exchanges.
Mint
an hour ago
- Mint
Wall Street rebounds as Fed rate cut bets intensify on weaker payrolls
(For a Reuters live blog on U.S., UK and European stock markets, click or type LIVE/ in a news window) Indexes up: Dow 1.06%, S&P 500 1.2%, Nasdaq 1.58% Tesla rises on 96 million share award to CEO Musk Spotify to raise premium subscription price, shares jump (Updates with analyst comment, early afternoon prices) By Nikhil Sharma and Pranav Kashyap Wall Street's main indexes bounced back on Monday after a sharp pullback in the previous session, buoyed by growing expectations of deeper Federal Reserve interest rate cuts following an unexpectedly weak jobs report. At 11:39 a.m. ET, the Dow Jones Industrial Average rose 463.55 points, or 1.06%, to 44,052.13, the S&P 500 gained 74.56 points, or 1.20%, to 6,312.57 and the Nasdaq Composite gained 325.95 points, or 1.58%, to 20,976.08. Both the S&P 500 and the Nasdaq were on track for their biggest single-day jump in more than two months. This is in contrast to Friday, when a dismal U.S. jobs report hammered the S&P 500 and sent it to its steepest intraday drop since May 27. The bleak data that also accompanied steep downward revisions for May and June forced market participants to amplify their bets for Fed rate cuts this year, noting signs of a weakening labor market. "When you have a Fed that operates in a lagging sense, you're going to have the market moving around as the data comes, that's what we're seeing with the weaker jobs report," said Charlie Ripley, senior investment strategist for Allianz Investment Management. Odds for a September rate cut now stand at about 84%, according to CME Fedwatch. Market participants see at least two quarter-point cuts by the end of this year. Underscoring uncertainty, Trump fired Bureau of Labor Statistics Commissioner Erika McEntarfer the same day, her of faking the jobs numbers. "The revisions ... it brings a level of skepticism into the data sets," Allianz Investment Management's Ripley added. Investors also weighed Fed Governor Adriana Kugler's unexpected resignation, which could open the door for President Donald Trump to reshuffle the central bank's leadership to his favor. Trump has repeatedly threatened to fire Chair Jerome Powell, believing that rates should be much lower than they are. Meanwhile, Tesla rose 1.2% after CEO Elon Musk 96 million shares worth about $29 billion. All S&P 500 sub-sectors were trading in the green, with communication services leading gains with a 2% jump. U.S. factory orders tumbled 4.8% in June after an upwardly revised 8.3% increase in May, owing to a sharp drop in commercial aircraft orders. Meanwhile, Trump threatened to substantially raise tariffs on India over its purchases of Russian oil. Last week, Trump slapped a 25% tariff on goods imported from the country. After a big week for Big Tech earnings, companies from various sectors, including Palantir, Eli Lilly and Disney, will report this week. Among notable movers, Joby Aviation rose 20.7% after Bloomberg News reported that the company was exploring the acquisition of helicopter ride-share operator Blade Air Mobility . Blade Air's shares surged 26.6%. IDEXX Laboratories soared 26.8% after the animal diagnostics maker its full-year profit and revenue forecasts and reported better-than-expected second-quarter results. Spotify jumped 6.8% as the music streaming platform announced plans to raise the monthly price of its premium individual subscription in select markets from September. Advancing issues outnumbered decliners by a 4.76-to-1 ratio on the NYSE and by a 2.8-to-1 ratio on the Nasdaq. The S&P 500 posted 25 new 52-week highs and seven new lows, while the Nasdaq Composite recorded 52 new highs and 72 new lows. (Reporting by Nikhil Sharma and Pranav Kashyap in Bengaluru; Editing by Maju Samuel)
